Paul Toren
Chercheur universitaire clinicien
Axe Oncologie
Métastases et progression du cancer
Oncologie clinique
Immunologie des tumeurs
Dernières nouvelles
Voir toutPublications
Voir tout-
article Leong DP, Higano C, Cano Garcia C, Fradet V, Siemens DR, Niazi T, Shayegan B, Guha A, Cirne F, Selvanayagam JB, Violette PD, Valle FH, Lavallée LT, Duceppe E, Anderson P, Xavier D, Lopez-Lopez JP, Villareal Trujillo N, Galapo Kann A, Piccoli RK, Mourtzakis M, Sarid D, Narasimha S, Luke PPW, Hajjar LA, Lukka H, Klotz L, Balasubramanian K, Mian R, Agapay S, Rangarajan S, Karampatos S, Ng KKH, Avezum A, Devereaux PJ, Pinthus JH and
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial
JAMA Intern Med 2026.
-
article Cano Garcia C, Pinthus J, Avezum A, Devereaux PJ, Klotz L, Higano C, Fradet V, Selvanayagam J, Guha A, Hajjar L, Lopez-Lopez JP, Xavier D, Ng K, Rangarajan S, Karampatos S, Agapay S, Mian R, Balasubramanian K, Cirne F, Huynh M, Davis MK, Hamilton RJ, Gopaul D, Mukherjee SD, Farooqi M, Benz AP, Richard R, Koo CYC, Leong DP and
Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral
JACC CardioOncol 2026.
-
article Suartz CV, Costa MSS, Matalani CFA, da Rocha MR, Micheleto JPC, Furlam PL, Lepine HL, Lopes RI, Talizin TB, Júnior JB, Shahrour W, Shabana W, Merseburger AS, Reis LO, Cordeiro MD, Nahas WC, Toren P, Ribeiro-Filho LA, Ploussard G, Fradet V, Pouliot F
Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis
Int Urol Nephrol 2026.
Projets
- Targeting sex steroids to improve the response to bladder cancer immunotherapy, du 2021-10-01 au 2026-09-30
- Repurposing bicalutamide to improve the response to immune checkpoint inhibition for treatment of advanced urothelial carcinoma, du 2022-08-01 au 2027-07-31
- Étude des interactions endo-immunitaires pour améliorer le traitement des carcinomes urothéliaux, du 2024-07-01 au 2028-06-30
- Circulating basophils and eosinophils as novel biomarkers for non-muscle invasive cancer bladder cancer, du 2024-09-01 au 2027-08-31
- Gut microbiota biomarkers to personalize treatment of bladder cancer, du 2024-12-01 au 2027-04-30
- Repurposing 5-alpha reductase inhibitors to improve outcomes for bladder cancer patients, du 2025-10-01 au 2030-09-30
- Investigation de la rôle des macrophages dans le progression du cancer de la prostate, du 2026-04-01 au 2031-03-31
- Evaluating CD163 Expression in Prostate Cancer Tissue Microarray Using Digital Pathology, du 2026-06-01 au 2027-05-30
- Mise en place de la plateforme d'ingénierie tissulaire en cancer, du 2023-09-01 au 2025-12-31